Tyrosinemia type II: nine cases of ocular signs and symptoms
- PMID: 11589874
- DOI: 10.1016/s0002-9394(01)01160-6
Tyrosinemia type II: nine cases of ocular signs and symptoms
Abstract
Purpose: To report nine cases of tyrosinemia type II, with ocular signs and symptoms.
Methods: Participants included nine patients (18 eyes) who were followed for a mean follow-up period of 6.5 years (range, 2 to 8 years). Intervention included dietary restriction of tyrosine and phenylalanine, which led to resolution of ocular and cutaneous lesions, improved behavior in one patient, and may have prevented developmental delay in others. The main outcome measures were visual acuity and serum tyrosine levels to determine the response to dietary therapy. Intelligence testing and developmental screening were performed when appropriate.
Results: All patients presented with ocular signs and symptoms as the primary manifestation of disease and serve to illustrate the typical ocular findings of this syndrome. Three patients presented with cutaneous manifestations, and one patient had mild mental impairment at the time of diagnosis.
Conclusions: Recalcitrant pseudodendritic keratitis may be the presenting sign in tyrosinemia type II. Awareness of the presenting signs and symptoms may accelerate the diagnosis and dietary intervention. Initiation of a tyrosine-restricted and phenylalanine-restricted diet in infancy is most effective in preventing cognitive impairment.
Similar articles
-
[Tyrosinemia type II. Case report].Bull Soc Belge Ophtalmol. 2005;(296):57-61. Bull Soc Belge Ophtalmol. 2005. PMID: 16050420 French.
-
Richner-Hanhart syndrome (tyrosinemia type II): a case report of delayed diagnosis with pseudodendritic corneal lesion.Turk J Pediatr. 2011 Nov-Dec;53(6):692-4. Turk J Pediatr. 2011. PMID: 22389994
-
Isolated corneal pseudodendrites as the initial manifestation of tyrosinemia type II in monozygotic twins.J Pediatr Ophthalmol Strabismus. 2012 May 8;49 Online:e33-6. doi: 10.3928/01913913-20120501-03. J Pediatr Ophthalmol Strabismus. 2012. PMID: 22588828
-
Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review.Ophthalmic Genet. 1995 Mar;16(1):21-6. doi: 10.3109/13816819509057850. Ophthalmic Genet. 1995. PMID: 7648039 Review.
-
The genetic tyrosinemias.Am J Med Genet C Semin Med Genet. 2006 May 15;142C(2):121-6. doi: 10.1002/ajmg.c.30092. Am J Med Genet C Semin Med Genet. 2006. PMID: 16602095 Review.
Cited by
-
Pseudodendritic keratitis in citrullinemia; a report of an unusual and novel ocular finding in this metabolic disorder.Am J Ophthalmol Case Rep. 2024 Mar 28;34:102044. doi: 10.1016/j.ajoc.2024.102044. eCollection 2024 Jun. Am J Ophthalmol Case Rep. 2024. PMID: 38601192 Free PMC article.
-
Creatine and pyruvate prevent the alterations caused by tyrosine on parameters of oxidative stress and enzyme activities of phosphoryltransfer network in cerebral cortex of Wistar rats.Mol Neurobiol. 2015;51(3):1184-94. doi: 10.1007/s12035-014-8791-9. Epub 2014 Jun 25. Mol Neurobiol. 2015. PMID: 24961569
-
Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II.Mol Cell Biochem. 2017 Nov;435(1-2):207-214. doi: 10.1007/s11010-017-3070-5. Epub 2017 May 25. Mol Cell Biochem. 2017. PMID: 28547180
-
Antibodies towards Tyrosine Amyloid-Like Fibrils Allow Toxicity Modulation and Cellular Imaging of the Assemblies.Molecules. 2018 May 26;23(6):1273. doi: 10.3390/molecules23061273. Molecules. 2018. PMID: 29861432 Free PMC article.
-
TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping.J Inherit Metab Dis. 2006 Oct;29(5):620-6. doi: 10.1007/s10545-006-0407-8. Epub 2006 Aug 17. J Inherit Metab Dis. 2006. PMID: 16917729
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
